GSK to raise elephantiasis drug output at Nasik unit
BRITISH drugmaker Glaxo-SmithKline (GSK) will increase its capacity to make a medicine for treatment of elephantiasis at its manufacturing facility in Nasik (India) besides its South African plant, a top company executive said.
GSK makes albendazole, a medicine used by 120 million people across the world, at its production units in Nasik and Cape Town.
Publication Date:
15/10/2010